Which joints are commonly involved in gout, and what is the first-line treatment for an acute gout flare?

Joints Affected by Gout and First-Line Treatment

Corticosteroids should be considered as first-line therapy for acute gout in patients without contraindications, as they are generally safer and lower cost than alternatives. 1

Joints Commonly Affected by Gout

Gout has a strong predilection for lower extremity joints, with a characteristic pattern of involvement:

• First metatarsophalangeal (MTP) joint of the great toe (podagra): This is the initial site in 50% of all gout cases 2, 3
• Other common sites include:
  • Tarsal and subtalar joints
  • Ankle
  • Knee
  • Midfoot 4

Less commonly affected joints include:

• Wrist
• Small joints of the hands
• Elbow 4, 5

Rare sites include axial joints and sternoclavicular joints, though these atypical presentations can lead to misdiagnosis 6. While acute gout typically presents as monoarticular arthritis, polyarticular involvement can occur, especially in patients with multiple comorbidities and those with contraindications to urate-lowering therapy 7.

First-Line Treatment for Acute Gout Flare

The 2017 American College of Physicians guideline provides clear direction: clinicians should choose from corticosteroids, NSAIDs, or colchicine to treat acute gout 1. However, the guideline specifically states that corticosteroids should be considered as first-line therapy because they are:

• Generally safer with fewer adverse effects compared to NSAIDs
• Low-cost
• As effective as NSAIDs for managing gout pain 1

Practical Dosing Algorithm:

Corticosteroids (First Choice):

• Prednisolone 35 mg daily for 5 days has been successfully used 1
• Contraindications: systemic fungal infections, known hypersensitivity
• Monitor for: blood glucose elevation, mood changes, fluid retention

NSAIDs (Alternative):

• Use at maximal dose if corticosteroids are contraindicated
• No evidence that indomethacin is superior to other NSAIDs (naproxen, ibuprofen work equally well) 1
• Contraindications: renal disease, heart failure, cirrhosis
• Consider PPI co-prescription for GI protection

Colchicine (Alternative):

• Use low-dose regimen: 1.2 mg followed by 0.6 mg 1 hour later (NOT the old high-dose regimen) 1
• More expensive than corticosteroids or NSAIDs
• Contraindications: severe renal or hepatic impairment, especially with concurrent CYP3A4 or P-glycoprotein inhibitors
• Common adverse effects: diarrhea, nausea, vomiting

Critical Pitfalls to Avoid:

1. Do NOT use high-dose colchicine (the old 1.2 mg followed by 0.6 mg hourly for 6 hours regimen) - it has equal efficacy but significantly more GI side effects 1

2. Do NOT assume indomethacin is superior - despite being traditionally considered "first-line NSAID," there is no evidence it outperforms other NSAIDs 1

3. Do NOT start urate-lowering therapy after a first attack - this is strongly recommended against unless there are special circumstances (tophi, chronic kidney disease, urolithiasis) 1

4. Serum uric acid levels during an acute flare are unreliable - they tend to decrease during attacks and do not confirm or exclude gout 4

The choice among these three options should be based on patient-specific contraindications, comorbidities, and cost considerations, but corticosteroids hold the preferred position when no contraindications exist 1.